Skeie, B., Øyvind Enger, P., Pedersen, P., & Olve Skeie, G. (2018). CMET-19. CLINICAL RISK ASSESSMENT SCORE TO ESTIMATE THE LIKELIHOOD OF PSEUDOPROGRESSION VERSUS TUMOR GROWTH FOLLOWING STEREOTACTIC RADIOSURGERY FOR BRAIN METASTASES. Neuro Oncol.
Citación estilo ChicagoSkeie, Bente, Per Øyvind Enger, Paal-Henning Pedersen, y Geir Olve Skeie. "CMET-19. CLINICAL RISK ASSESSMENT SCORE TO ESTIMATE THE LIKELIHOOD OF PSEUDOPROGRESSION VERSUS TUMOR GROWTH FOLLOWING STEREOTACTIC RADIOSURGERY FOR BRAIN METASTASES." Neuro Oncol 2018.
Cita MLASkeie, Bente, Per Øyvind Enger, Paal-Henning Pedersen, y Geir Olve Skeie. "CMET-19. CLINICAL RISK ASSESSMENT SCORE TO ESTIMATE THE LIKELIHOOD OF PSEUDOPROGRESSION VERSUS TUMOR GROWTH FOLLOWING STEREOTACTIC RADIOSURGERY FOR BRAIN METASTASES." Neuro Oncol 2018.